Table 5.
Prognostic impact of triglyceride-glucose index after propensity score matching
| Outcome | No. (%) | Unadjusted | Multivariable Adjusted | |||
|---|---|---|---|---|---|---|
| ≤ 8.99 | > 8.99 | HR (95% CI) | P value | HR (95% CI) | P value | |
| MACE | 44 (16.6) | 67 (25.3) | 1.60 (1.10–2.34) | 0.015 | 1.70 (1.15–2.50) | 0.007 |
| All-cause death | 33 (12.5) | 49 (18.5) | 1.52 (0.98–2.37) | 0.061 | 1.66 (1.06–2.59) | 0.027 |
| Non-fatal myocardial infarction | 8 (3.0) | 16 (6.0) | 2.10 (0.90–4.91) | 0.086 | 2.05 (0.88–4.81) | 0.097 |
| Non-fatal stroke | 3 (1.1) | 5 (1.9) | 1.72 (0.41–7.21) | 0.456 | 1.53 (0.36–6.47) | 0.564 |
| Gastrointestinal bleeding | 11 (4.2) | 14 (5.3) | 1.30 (0.59–2.86) | 0.516 | 1.24 (0.56–2.73) | 0.599 |
CI, confidence interval; HR, hazard ratio; MACE, major adverse cardiovascular events